GENTEX CORP·4

Nov 1, 11:35 AM ET

Wallace James H 4

4 · GENTEX CORP · Filed Nov 1, 2022

Insider Transaction Report

Form 4
Period: 2022-10-31
Transactions
  • Exercise/Conversion

    Common Stock

    2022-10-31$18.70/sh+7,000$130,90021,709 total
  • Exercise/Conversion

    Non-Employee Director Stock Option Grant

    2022-10-317,0000 total
    Exercise: $24.21From: 2018-11-17Exp: 2028-05-17Common Stock (7,000 underlying)
  • Sale

    Common Stock

    2022-10-31$26.04/sh14,000$364,54714,709 total
  • Exercise/Conversion

    Common Stock

    2022-10-31$24.21/sh+7,000$169,47028,709 total
  • Exercise/Conversion

    Non-Employee Director Stock Option Grant

    2022-10-317,0000 total
    Exercise: $18.70From: 2017-11-18Exp: 2027-05-18Common Stock (7,000 underlying)
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $25.89 to $26.135. The price reported above reflects the weighted average price.

Documents

2 files